
    
      In order to monitor drug-induced liver injury or other adverse drug reactions of
      Shujinjianyao Pill in clinical real world, registry study is a suitable method in this area.
      Meanwhile, the investigators will use nested case-control study to find out the mechanism of
      drug-induced liver injury. Calculate the incidence of drug-induced liver injury or other
      adverse drug reactions is one of the main aims for this study. Therefore, Safety monitoring
      of Shujinjianyao Pill is an very important problem that needs to be done through a large
      sample observational study. According to the relevant regulations of the state drug
      administration(SDA), 3000 cases need to be registered at least. The aim population is who use
      Shujinjianyao Pill with normal liver function before medication from June 2018 to October
      2019.
    
  